Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kelesitse Phiri, Jesper Hallas, Marie Linder, Andrea Margulis, Brandon Suehs, Alejandro Arana, Shahram Bahmanyar, Veena Hoffman, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susana Perez-Gutthann, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel & John Seeger. (2021) A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Current Medical Research and Opinion 37:5, pages 867-877.
Read now
Read now
Articles from other publishers (4)
Claudia Sanjinez, Edoardo Botteri, Nathalie C Støer & L Lukas Löfling. (2023) Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study. Lung Cancer 179, pages 107187.
Crossref
Crossref
Gloria M. Calaf, Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo & Tammy C. Bleak. (2022) Muscarinic Receptors Associated with Cancer. Cancers 14:9, pages 2322.
Crossref
Crossref
Nina A. Hering, Verena Liu, Rayoung Kim, Benjamin Weixler, Raoul A. Droeser, Marco Arndt, Ioannis Pozios, Katharina Beyer, Martin E. Kreis & Hendrik Seeliger. (2021) Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma. Cancers 13:13, pages 3220.
Crossref
Crossref
Justyna Magdalena Hermanowicz, Iwona Kwiatkowska & Dariusz Pawlak. (2020) Important players in carcinogenesis as potential targets in cancer therapy: an update. Oncotarget 11:32, pages 3078-3101.
Crossref
Crossref